PIK3CA mutations and PTEN loss are considered to be nearly mutually exclusive in breast tumors [11, 14], a characteristic shared by our series, as only four tumors presented concomitantly a PTEN deletion and a PIK3CA activating mutation (one in exon 9, three in exon 20, Table 2). This evidence concerns the gene PIK3CA and breast neoplasm.